Product Information
BUDESONIDE 0.5 MG/2 ML SUSP is a generic product labeled by Cipla USA Inc., priced at $0.6761 per ML under NDC 69097031987. Its NADAC has been published 446 times since Mar 21, 2018.
FDA first approved this application on Nov 16, 2017. Its Orange Book therapeutic-equivalence code is AN.
Strength
.5 mg/2mL
Manufacturer
Cipla USA Inc.NDC
69097031987
Classification
Generic
Dosage Form
INHALANT
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205710FDA Approved
11/16/2017
TE Code
AN
On Market Since
11/16/2017
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE 0.5 MG/2 ML SUSP has been published 446 times since Mar 21, 2018, and over the history we have for it it has declined 53.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6761 per ML |
|---|---|
| All-time high | $1.4495 (Apr 11, 2018) |
| All-time low | $0.4949 (Jan 18, 2023) |
| 52-week high | $0.8003 |
| 52-week low | $0.6761 |
| Median price | $0.7650 |
| Average price | $0.7761 |
| Largest weekly change | +30.9% (Aug 23, 2023) |
| Weeks tracked | 446 |
| Tracking since | Mar 21, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Budesonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUDESONIDE 0.5 MG/2 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE 0.5 MG/2 ML SUSP, manufactured by Cipla USA Inc., is $0.6761 per ML (NDC 69097031987), effective Sep 30, 2026.
How has the price of BUDESONIDE 0.5 MG/2 ML SUSP changed over time?
Over the history we have for it, the NADAC for BUDESONIDE 0.5 MG/2 ML SUSP has declined 53.4%. It has been tracked across 446 weekly CMS publications since Mar 21, 2018.
What are the highest and lowest recorded NADAC prices for BUDESONIDE 0.5 MG/2 ML SUSP?
Since Mar 21, 2018, the NADAC for BUDESONIDE 0.5 MG/2 ML SUSP has ranged from a low of $0.4949 (Jan 18, 2023) to a high of $1.4495 (Apr 11, 2018), with a median of $0.7650 per ML.
Are there cheaper alternatives to BUDESONIDE 0.5 MG/2 ML SUSP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUDESONIDE 0.5 MG/2 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures BUDESONIDE 0.5 MG/2 ML SUSP?
BUDESONIDE 0.5 MG/2 ML SUSP (NDC 69097031987) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.